Practice
Featured experience
Chime $993.6 million IPO
The shares are listed on the Nasdaq Global Select Market
Cipher Mining 300 MW, $5.5 billion lease agreement with Amazon Web Services
We advised Cipher Mining on the transaction
Diameter Capital Partners $4.5 billion fundraise for its third dislocation fund
We advised Diameter on the transaction
Banco Santander $12.2 billion acquisition of Webster Bank
We are advising Banco Santander on the transaction
Medallion Bank Initial Public Offering of Preferred Shares
Davis Polk advised the underwriters in connection with Medallion Bank’s initial public offering of 1,840,000 shares of…
Medallion Bank Initial Public Offering of Preferred Shares
Davis Polk advised the underwriters in connection with Medallion Bank’s initial public offering of 1,840,000 shares of…
New Jersey Resources Corporation Common Stock Offering and Forward Sale Agreements
Davis Polk advised the forward purchasers and the forward sellers in connection with the execution of forward sale…
New Jersey Resources Corporation Common Stock Offering and Forward Sale Agreements
Davis Polk advised the forward purchasers and the forward sellers in connection with the execution of forward sale…
Medallion Bank Initial Public Offering of Preferred Shares
Davis Polk advised the underwriters in connection with Medallion Bank’s initial public offering of 1,840,000 shares of…
New Jersey Resources Corporation Common Stock Offering and Forward Sale Agreements
Davis Polk advised the forward purchasers and the forward sellers in connection with the execution of forward sale…
JB Financial Group acquisition of Morgan Stanley Gateway Securities
Davis Polk is advising JB Financial Group Co., Ltd. on its acquisition of Morgan Stanley Gateway Securities J.S.C. (“MSGS”)…
Davis Polk Advises Charles River on Its Acquisition of HemaCare
Davis Polk is advising Charles River Laboratories International, Inc. on its approximately $380 million acquisition of…
China South City Holdings Limited $150 Million High-Yield Notes Offering
Davis Polk advised the initial purchasers in connection with a $150 million Regulation S only offering by China South City…
Davis Polk Advises Charles River on Its Acquisition of HemaCare
Davis Polk is advising Charles River Laboratories International, Inc. on its approximately $380 million acquisition of…